Objective SLE is a chronic autoimmune disorder with a range of symptoms. While these are broadly reported in the literature, ...

Timely diagnosis of systemic lupus erythematosus (SLE) is of critical clinical importance because it allows for an early start to treatment, preventing organ damage and improving the patient’s quality ...

Objective Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly recognised for benefits beyond glycaemic ...

Introduction Patients with SLE have an increased risk of infections and infection-related mortality, which may be associated ...

Systemic lupus erythematosus (SLE) is an exceptionally heterogeneous disease, characterized by a wide spectrum of constitutional and organ-specific manifestations, complications and comorbidities.

Dear Dr. Roach: What is lupus, and what does it do to your body? I just had a friend diagnosed with it after many months of tests. — T.S.B. Dear T.S.B.: The term "lupus" generally means systemic lupus ...

Elevated interferon levels are independently linked to key metabolic abnormalities in SLE, including dyslipidemia and pancreatic β‑cell dysfunction.

Adenosine deaminase 2 deficiency (DADA2) is an inborn error of immunity leading to systemic vasculitis, haematological manifestations, immune deficiency and/or autoimmunity. We report the case of a 26 ...